Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Snakebite risk mapping could save lives in africa

NCT ID NCT06808789

Knowledge-focused Sponsor: Liverpool School of Tropical Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 01, 2026 · Updated 2 times

Summary

This study will survey 32,000 households in Ghana and Rwanda to understand where snakebites happen most. Researchers will use GPS and computer models to create risk maps. The goal is to help health officials send antivenom to the areas that need it most and plan prevention efforts.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could create accurate risk maps to guide antivenom supplies and prevention programs in high-risk areas of sub-Saharan Africa.
What could go wrong
This is an observational study, not a treatment trial. The risk maps may not perfectly predict snakebite locations, and results may not apply to other regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 32,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population comprises all residents in Ghana and Rwanda who are at risk of snakebite.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Household Screening Questionnaire: o Heads of household from all selected households will be invited to participate, regardless of age or sex. If the head of household is absent, another adult from the household who can report on behalf of all household members will be invited to be interviewed. * Snakebite Details Questionnaire: * All household members identified with a history of snakebite will be invited to complete this questionnaire, with the assistance/in the presence of a responsible adult if the participant is a minor. If the household member is deceased, a responsible adult from the household will be asked to complete the questionnaire as far as possible. Exclusion Criteria: * Household Screening Questionnaire * Households where the household head/a responsible adult is not present at first visit or revisit. * Households where the household head/responsible adult is unable or unwilling to give consent. * Snakebite Details Questionnaire * Where the snakebite victim is an adult and is present: the victim is unwilling to participate * Where the snakebite victim is an adult and is not present: there is no responsible adult who is able to complete the questionnaire on the behalf of the victim * Where the snakebite victim is a minor: there is no responsible adult who is able or willing to provide consent to be interviewed or support the child to complete the questionnaire.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Snake envenomation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Snake Bites snakebite envenomation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Snake envenomation Snakebite

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Asante Akim South Municipal Health Directorate

    RECRUITING

    Kumasi, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.